pBR322 vectors having tetracycline-dependent replication

Area of Science:

• Molecular Biology
• Bacterial Genetics

Background:

• Escherichia coli cloning vectors require stable maintenance and efficient curing.
• The pAM34 plasmid, a pBR332 derivative, relies on lacZYA promoter regulation, limiting its use with other lac-regulated systems.

Purpose of the Study:

• To modify the pAM34 plasmid by replacing lac regulatory elements.
• To develop novel Escherichia coli cloning vectors with improved regulatory control and curing efficiency.

Main Methods:

• Replacement of lac regulatory elements in pAM34 with the Tn10 tetracycline resistance module.
• Characterization of the resulting tetracycline-dependent plasmids in Escherichia coli.

Main Results:

• Generated medium copy number plasmids dependent on tetracycline for replication.
• Demonstrated rapid plasmid loss in the absence of tetracycline.
• Showed accelerated plasmid loss in hosts expressing tetracycline efflux pumps.

Conclusions:

• The modified pAM34 plasmids provide tetracycline-inducible replication, enabling efficient curing.
• These new vectors overcome limitations of lac-regulated systems, expanding cloning vector options for Escherichia coli.